Based on evidence that T cell exhaustion might affect the course of JCV infections, ICIs are currently tested for treatment of PML.47 For example, Cortese et al48 assessed the safety and efficacy of PD-1 inhibition by pembrolizumab with different predisposing conditions (n=8). The gene discussed is PDCD1; the disease is progressive multifocal leukoencephalopathy.